Zentalis Pharmaceuticals, Inc. Quarterly Goodwill in USD from Q4 2019 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.
Summary
Zentalis Pharmaceuticals, Inc. quarterly Goodwill history and growth rate from Q4 2019 to Q3 2024.
  • Zentalis Pharmaceuticals, Inc. Goodwill for the quarter ending September 30, 2024 was $3.74M, unchanged year-over-year.
Goodwill, Quarterly (USD)
Goodwill, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 $3.74M $0 0% Sep 30, 2024 10-Q 2024-11-12
Q2 2024 $3.74M $0 0% Jun 30, 2024 10-Q 2024-08-09
Q1 2024 $3.74M $0 0% Mar 31, 2024 10-Q 2024-05-07
Q4 2023 $3.74M $0 0% Dec 31, 2023 10-Q 2024-11-12
Q3 2023 $3.74M $0 0% Sep 30, 2023 10-Q 2023-11-06
Q2 2023 $3.74M $0 0% Jun 30, 2023 10-Q 2023-08-09
Q1 2023 $3.74M $0 0% Mar 31, 2023 10-Q 2023-05-10
Q4 2022 $3.74M $0 0% Dec 31, 2022 10-K 2024-02-27
Q3 2022 $3.74M $0 0% Sep 30, 2022 10-Q 2022-11-09
Q2 2022 $3.74M $0 0% Jun 30, 2022 10-Q 2022-08-09
Q1 2022 $3.74M $0 0% Mar 31, 2022 10-Q 2022-05-05
Q4 2021 $3.74M $0 0% Dec 31, 2021 10-K 2023-03-01
Q3 2021 $3.74M $0 0% Sep 30, 2021 10-Q 2021-11-10
Q2 2021 $3.74M $0 0% Jun 30, 2021 10-Q 2021-08-12
Q1 2021 $3.74M $0 0% Mar 31, 2021 10-Q 2021-05-17
Q4 2020 $3.74M $0 0% Dec 31, 2020 10-K 2022-02-24
Q3 2020 $3.74M Sep 30, 2020 10-Q 2020-11-09
Q2 2020 $3.74M Jun 30, 2020 10-Q 2020-08-13
Q1 2020 $3.74M Mar 31, 2020 10-Q 2020-05-15
Q4 2019 $3.74M Dec 31, 2019 10-K 2021-03-25
* An asterisk sign (*) next to the value indicates that the value is likely invalid.